Form D Explorer
Chronicle Bio, Inc. · CIK 2090889

Report a data issueCitable research briefCompare issuerPrivate research collection

Chronicle Bio, Inc.

CIK 2090889 · Corporation · Inc. DELAWARE · Menlo Park, California · Other Technology

Filing history at a glance

The two most recent stored filings share the date Nov 12, 2026. The filing dates alone do not show which came first. The displayed filing reports $16,000,000 offered. Amendments account for 4 of the 6 filings stored from Oct 15, 2025 to Nov 12, 2026.

Filings
6
Original notices
2
Amendments
4
Activity
Oct 15, 2025
through Nov 12, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Both filings have the same date. Their sequence is unknown; directional differences are suppressed.

Unavailable values are shown as a dash; reported zero remains zero.
FieldNov 12, 2026 · DNov 12, 2026 · D/ALater minus earlier
Reported offering amount$1,000,000$16,000,000—
Reported amount sold$250,000$15,366,000—
Reported investor count150—
Reported minimum investment$0$0—

Earlier SEC source: 0002090889-26-000003 · Later SEC source: 0002090889-26-000004

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D/A · Nov 12, 2026

Reported offering amount
$16,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$15,366,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (6)